169 related articles for article (PubMed ID: 12401702)
1. The role of mini-allotransplants in the treatment of solid tumors.
Schouten HC
Ann Oncol; 2002; 13 Suppl 4():281-6. PubMed ID: 12401702
[No Abstract] [Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation.
Kai S; Hara H
Ther Apher Dial; 2003 Jun; 7(3):285-91. PubMed ID: 12924602
[TBL] [Abstract][Full Text] [Related]
3. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
[No Abstract] [Full Text] [Related]
4. High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancer.
Pedrazzoli P; Tarenzi E; Tullio C; Colosini G; Siena S
J Chemother; 2004 Nov; 16 Suppl 4():108-11. PubMed ID: 15688624
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term safety of the 2 x 10(6) CD34+ cells/kg threshold for hematopoietic reconstitution after high-dose chemotherapy and peripheral blood progenitor cell support.
Corsini C; Bertolini F; Mancuso P; Cinieri S; Peccatori F; Martinelli G
Ann Oncol; 2002 Jun; 13(6):983-5. PubMed ID: 12123347
[No Abstract] [Full Text] [Related]
6. [Bone marrow transplantation in oncology].
Tiuliandin SA
Vopr Onkol; 1991; 37(3):259-65. PubMed ID: 2031319
[No Abstract] [Full Text] [Related]
7. Treatment strategies in childhood cancer.
Alcoser PW; Rodgers C
J Pediatr Nurs; 2003 Apr; 18(2):103-12. PubMed ID: 12720207
[TBL] [Abstract][Full Text] [Related]
8. Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors.
Renga M; Pedrazzoli P; Siena S
Ann Oncol; 2003 Aug; 14(8):1177-84. PubMed ID: 12881372
[TBL] [Abstract][Full Text] [Related]
9. [High-dose chemotherapy with stem cell support for solid tumors in adults].
Rodenhuis S; de Vries EG
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
[TBL] [Abstract][Full Text] [Related]
10. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.
Appelbaum FR
CA Cancer J Clin; 1996; 46(3):142-64. PubMed ID: 8646545
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
McGuire WP
Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
[TBL] [Abstract][Full Text] [Related]
12. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
13. [Hematopoietic stem cell transplantation ("Bone marrow graft"): indications, methods and risks].
Beguin Y
Rev Med Liege; 1996 Apr; 51(4):270-5. PubMed ID: 8693220
[No Abstract] [Full Text] [Related]
14. Acute graft-versus-host disease following hematopoietic stem-cell transplantation.
Hu SW; Cotliar J
Dermatol Ther; 2011; 24(4):411-23. PubMed ID: 21910799
[TBL] [Abstract][Full Text] [Related]
15. Is there an upper age limit for bone marrow transplantation?
Popplewell LL; Forman SJ
Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
[TBL] [Abstract][Full Text] [Related]
16. The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature.
Jethwa KD; Bishton MJ; Fox CP
Br J Haematol; 2017 Aug; 178(3):476-479. PubMed ID: 27146257
[No Abstract] [Full Text] [Related]
17. [Allogeneic hematopoietic stem cell transplantation for solid tumors].
Kanda Y
Rinsho Ketsueki; 2004 Mar; 45(3):189-94. PubMed ID: 15103931
[No Abstract] [Full Text] [Related]
18. [About allogenic stem cell transplantation among children].
Vettenranta K
Duodecim; 2005; 121(24):2712-3. PubMed ID: 16454255
[No Abstract] [Full Text] [Related]
19. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
[TBL] [Abstract][Full Text] [Related]
20. The use of autologous transplantation in the treatment of malignant disorders.
Territo M
J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
